ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05321	Inflammatory bowel disease (IBD)	8/95	56/7206	5.72477038058e-07
ko04621	NOD-like receptor signaling pathway	12/95	157/7206	8.62458124495e-07
ko04060	Cytokine-cytokine receptor interaction	13/95	191/7206	1.10091387855e-06
ko05340	Primary immunodeficiency	6/95	30/7206	2.06005403175e-06
ko05168	Herpes simplex infection	12/95	182/7206	4.11908417331e-06
ko05140	Leishmaniasis	8/95	75/7206	5.53896718693e-06
ko05150	Staphylococcus aureus infection	6/95	36/7206	6.34050575152e-06
ko05164	Influenza A	11/95	167/7206	1.08010259084e-05
ko05162	Measles	9/95	120/7206	2.57420124575e-05
ko05145	Toxoplasmosis	9/95	126/7206	3.79899145983e-05
ko04630	Jak-STAT signaling pathway	9/95	132/7206	5.48552718327e-05
ko04612	Antigen processing and presentation	7/95	77/7206	6.28093615713e-05
ko04672	Intestinal immune network for IgA production	5/95	37/7206	0.000111842258333
ko05152	Tuberculosis	10/95	187/7206	0.000162399428338
ko04658	Th1 and Th2 cell differentiation	7/95	96/7206	0.000254048312636
ko05144	Malaria	5/95	45/7206	0.000288460314122
ko04514	Cell adhesion molecules (CAMs)	8/95	130/7206	0.000294813337232
ko04620	Toll-like receptor signaling pathway	7/95	100/7206	0.000326910615831
ko04380	Osteoclast differentiation	8/95	134/7206	0.000362284032334
ko04659	Th17 cell differentiation	7/95	106/7206	0.00046679361303
ko04610	Complement and coagulation cascades	6/95	79/7206	0.000573912210935
ko05416	Viral myocarditis	5/95	55/7206	0.000740391745063
ko05323	Rheumatoid arthritis	6/95	89/7206	0.00107970196298
ko04622	RIG-I-like receptor signaling pathway	5/95	62/7206	0.00128092710868
ko04217	Necroptosis	8/95	178/7206	0.00230913879436
ko05330	Allograft rejection	3/95	24/7206	0.00367567549147
ko05160	Hepatitis C	7/95	153/7206	0.0039332078286
ko04062	Chemokine signaling pathway	8/95	201/7206	0.00485984187616
ko04611	Platelet activation	7/95	163/7206	0.00555728254554
ko05133	Pertussis	5/95	87/7206	0.00565134003239
ko05320	Autoimmune thyroid disease	3/95	29/7206	0.00632791757352
ko05161	Hepatitis B	7/95	173/7206	0.00764068843876
ko04064	NF-kappa B signaling pathway	5/95	96/7206	0.00852312155152
ko04933	AGE-RAGE signaling pathway in diabetic complications	6/95	135/7206	0.00861045230043
ko04650	Natural killer cell mediated cytotoxicity	5/95	97/7206	0.00889461455744
ko04640	Hematopoietic cell lineage	4/95	64/7206	0.0098539928011
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/95	191/7206	0.0127756325637
ko04670	Leukocyte transendothelial migration	6/95	151/7206	0.0144404768473
ko05166	HTLV-I infection	9/95	292/7206	0.0144563671069
ko05134	Legionellosis	4/95	74/7206	0.016158033087
ko04664	Fc epsilon RI signaling pathway	4/95	77/7206	0.0184474398897
ko05169	Epstein-Barr virus infection	7/95	206/7206	0.0186628988667
ko04145	Phagosome	6/95	162/7206	0.0197727017327
ko05310	Asthma	2/95	17/7206	0.0205658574816
ko05131	Shigellosis	4/95	82/7206	0.0226925381853
ko05332	Graft-versus-host disease	2/95	18/7206	0.0229404493752
ko04660	T cell receptor signaling pathway	5/95	124/7206	0.0235815579425
ko05212	Pancreatic cancer	4/95	83/7206	0.0236072341108
ko00254	Aflatoxin biosynthesis	1/95	2/7206	0.0261949185303
ko04072	Phospholipase D signaling pathway	6/95	197/7206	0.0452469503101